Cytokinetics (CYTK) says it's received notice from The Nasdaq Stock Market confirming that for...
Cytokinetics (CYTK) says it's received notice from The Nasdaq Stock Market confirming that for the last 10 consecutive business days, the closing bid price of its stock has been at $1.00 per share or greater, therby regained compliance with listing rules.
From other sites
at CNBC.com (Jul 1, 2013)
at CNBC.com (Jun 26, 2013)
at CNBC.com (Jun 25, 2013)
at CNBC.com (May 10, 2010)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs